Drug Information Insights & Events

Learn how Elsevier's industry experts are helping clients solve drug information challenges and improve medication safety; meet with us at industry gatherings.

Latest Insight

medication alternatives

Improved Chronic Disease Management with
Alternative Healthcare Delivery

Learn how alternative healthcare delivery models, such as convenient care clinics and patient-centered medical homes, are expanding options for chronic disease management to improve health outcomes, contain costs, and build meaningful connections with members.

Read More


Clinical Drug Information—Significance of True Daily Updates
All drug databases are NOT created equal. Discover how Elsevier’s modern approach to managing drug information and TRUE Daily Updates™ will benefit your organization.

Controlling Prescription Drug Abuse
Controlling Prescription Drug Abuse examines what pharmacies need to know about controlled substance abuse.

Rising Generic Drug Prices: Impact of Biosimilars
Whitepaper discusses policy issues, success factors and the potential impact of biosimilars on drug prices and healthcare.

Medicine Adherence and Star Ratings
According to the Centers for Disease Control and Prevention (CDC), the direct cost of medicine non-adherence is estimated at $100 billion to $289 billion annually. Improving medication adherence is critical to patients, health care providers, health insurers, pharmacy and other stakeholders, because increased adherence equates to improved outcomes.

More Whitepapers

Case Studies

Achieving MAC Optimization & Transparency with Predictive Acquisition Cost (PAC)
By using PAC, payers and PBMs can balance their MAC lists quickly and improve pharmacy relations.

Tufts Medical Center Reduces Costs of up to $70k with Clinical Pharmacology
Learn how the medical center utilized Elsevier's  point of care drug information system to reduced errors and  costs.

More Case Studies